ENVERIC BIOSCIENCES, INC.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-9.1M | $-2.8M | $-814.1K | $-33.6K | $-161 | $-24.6K | $-33.4K | $-39.4K |
| Depreciation & Amortization | $3.2M | $1.4M | $166.2K | $116 | — | — | — | — |
| Depreciation | — | $1.4M | $166.3K | $116 | — | — | — | — |
| Amortization | $3.2M | $1.4M | $164.8K | — | — | — | — | — |
| Stock-Based Compensation | $7.1M | $1.5M | — | — | — | — | — | — |
| Net Cash from Operating Activities | $-2.7M | $-2.7M | $-3.9M | $-43.2K | $-21.6K | $-24.9K | $-30.3K | $-40.7K |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | $165.0K | $6.6M | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-169.9K | $-6.6M | $-1.8M | $-3.2K | — | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $6.4M | $8.8M | $6.2M | $48.0K | $20.5K | $8.0K | $47.5K | $40.0K |
| Net Change in Cash | $3.5M | $-498.1K | $497.0K | $1.4K | $-1.1K | $-16.9K | $17.1K | $-666 |
| Free Cash Flow | — | — | — | — | — | — | — | — |